Evidence map›Paper›PMID 18793185›Full record

ArticleBiochemical Society transactions2008

High-resolution mass spectrometry analysis of protein oxidations and resultant loss of function.

Stephen Barnes, Erin M Shonsey, Shannon M Eliuk, David Stella, Kerri Barrett, Om P Srivastava, Helen Kim, Matthew B Renfrow

Abstract read
In one paragraph

Article in Biochemical Society transactions, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Interdisciplinary toxicology · 2018
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Stephen BarnesDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA. sbarnes@uab.edu
Erin M Shonsey
Shannon M Eliuk
David Stella
Kerri Barrett
Om P Srivastava
Helen Kim
Matthew B Renfrow

Funding

PROJECT 4 - POLYPHENOLS AND DAMAGE IN THE EYEP50AT000477 · NCCIH · PURDUE UNIVERSITY WEST LAFAYETTE · PI WEAVER, CONNIE MARIE · 2000 to 2010
$15.0M
Center for Nutrient-Gene Interaction in Cancer PreventionU54CA100949 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARNES, STEPHEN · 2003 to 2008
$9.7M
9.4 Tesla Fourier Transform Mass SpectrometerS10RR017261 · NCRR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARNES, STEPHEN · 2002 to 2002
$1.5M
HUMAN AMINO ACID CONJUGATION OF BILE ACIDSR01DK046390 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARNES, STEPHEN · 1994 to 2006
$1.0M
NCCIH NIH HHS P50 AT000477NCCIH NIH HHS P50 AT00477NCI NIH HHS U54 CA100949NCRR NIH HHS S10 RR017261NCRR NIH HHS S10 RR17261NIDDK NIH HHS R01 DK046390NIDDK NIH HHS R01 DK46390
6 · The paper itself

Abstract

MS, with or without pre-analysis peptide fractionation, can be used to decipher the residues on proteins where oxidative modifications caused by peroxynitrite, singlet oxygen or electrophilic lipids have occurred. Peroxynitrite nitrates tyrosine and tryptophan residues on the surface of actin. Singlet oxygen, formed by the interaction of UVA light with tryptophan, can oxidize neighbouring cysteine, histidine, methionine, tyrosine and tryptophan residues. Dose-response inactivation by 4HNE (4-hydroxynonenal) of hBAT (human bile acid CoA:amino acid N-acyltransferase) and CKBB (cytosolic brain isoform of creatine kinase) is associated with site-specific modifications. FT-ICR (Fourier-transform ion cyclotron resonance)-MS using nanoLC (nano-liquid chromatography)-ESI (electrospray ionization)-MS or direct-infusion ESI-MS with gas-phase fractionation identified 14 4HNE adducts on hBAT and 17 on CKBB respectively. At 4HNE concentrations in the physiological range, one member of the catalytic triad of hBAT (His362) was modified; for CKBB, although all four residues in the active site that were modifiable by 4HNE were ultimately modified, only one, Cys283, occurred at physiological concentrations of 4HNE. These results suggest that future in vivo studies should carefully assess the critical sites that are modified rather than using antibodies that do not distinguish between different modified sites.

Indexed as

AcyltransferasesCreatine Kinase, BB FormOxidation-ReductionAldehydesalpha-Crystallin B ChainAmino Acid SequenceBinding SitesCysteine Proteinase InhibitorsHumansMass SpectrometryMolecular Sequence DataOxidative StressSpectroscopy, Fourier Transform Infrared4-hydroxy-2-nonenalAcyltransferasesAldehydesalpha-Crystallin B Chainbile acid-CoA amino acid N-acyltransferaseCreatine Kinase, BB FormCRYAB protein, humanCysteine Proteinase Inhibitors

Identifiers

PMID18793185
PMCPMC2715854

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.